Revance Therapeutics Inc (RVNC)

[Mufaso]

The Securities Exchange Act of 1934 Regulation 13D requires beneficial owners of more than 5% of a class of equity securities of a publicly traded company to file a report with the SEC within 10 business days of crossing 5% (either way). This would apply to Crown if they purchased enough shares (e.g. more than approx. 5.25 million) as well as Teoxane (falling below 5.25 million shares).

https://www.investmentfundlawblog.com/resources/investments-by-funds/acquiring-5-publicly-traded-company/

If either Crown acquired and crossed the threshold of 5%, more than 10 business days ago, they would have had to file a form with the SEC. Same goes for TEOXANE for selling enough to fall below 5%.

Neither has filed a report yet but 10 business days was Sept 16 and 20 that's when 20 M shares traded, the stock dropped below 6 for the first time since the deal was announced.